Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

All Headings will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Cancer Data Access System (CDAS)

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office	ID
LeeVan, Elyse, M.D., M.P.H. elyse.leevan@nih.gov 240-276-7314	5E212	Program Officer \| Early Detection	658
McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection	2611
Miller, Eric, Ph.D. eric.miller2@nih.gov 240-276-5336	5E230	Program Officer \| Early Detection	591
Ong, Mary Jane maryjane.ong@nih.gov 240-858-3296	5E112	Nurse Consultant \| Early Detection	2546
Pinsky, Paul, Ph.D. paul.pinsky@nih.gov 240-276-7014	5E108	Chief \| Early Detection	608
Saxena, Neeraj, Ph.D. neeraj.saxena@nih.gov 240-276-6302	5E218	Program Officer \| Early Detection	622
Zhu, Claire, Ph.D. claire.zhu@nih.gov 240-276-7013	5E106	Program Officer \| Early Detection	645

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Ghobrial, Irene M.	Dana-Farber Cancer Inst United States	Molecular prediction of myeloma in African Americans	5U01CA271492-03	Claire Zhu, Ph.D.
Grogan, Eric L	Vanderbilt University Medical Center United States	Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules	5R01CA252964-05	Claire Zhu, Ph.D.
Hayes, Richard Bernard	New York University School Of Medicine United States	The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer	5R01CA159036-09	Claire Zhu, Ph.D.
Hruska, Carrie B	Mayo Clinic Rochester United States	Density MATTERS Clinical Trial	5R01CA239200-05	Claire Zhu, Ph.D.
Hsu, Li	Fred Hutchinson Cancer Center United States	Statistical Methods for Precision Prevention	1R01CA297681-01	Claire Zhu, Ph.D.
James, Aimee S	Washington University United States	Building equity in cancer screening through research: The Siteman Catchment CSRN Hub	5UG1CA286946-02	Elyse LeeVan, M.D., M.P.H.
Ji, Hanlee P	Stanford University United States	Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection	1U01CA282212-01A1	Claire Zhu, Ph.D.
Kanetsky, Peter A	H. Lee Moffitt Cancer Ctr & Res Inst United States	A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers	1R01CA291735-01	Claire Zhu, Ph.D.
Kim, Michelle Kang	Cleveland Clinic Lerner Com-Cwru United States	Assessing feasibility of gastric cancer screening in the US	1R37CA300540-01	Claire Zhu, Ph.D.
Kooperberg, Charles L	Fred Hutchinson Cancer Center United States	Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN)	5UG1CA287013-02	Elyse LeeVan, M.D., M.P.H.
Krist, Alexander H	Virginia Commonwealth University United States	Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub)	3UG1CA287017-02S1	Elyse LeeVan, M.D., M.P.H.
Lee, Jeffrey Kuang Zou	Kaiser Foundation Research Institute United States	Vanguard Study Administrative Supplement	3UG1CA287011-02S1	Elyse LeeVan, M.D., M.P.H.
Livneh, Zvi	Weizmann Institute Of Science United States	Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort	5U01CA279001-03	Claire Zhu, Ph.D.
Lowry, Kathryn Paige	University Of Washington United States	Evaluation of Commercial Mammography-Based Artificial Intelligence Algorithms for Breast Cancer Risk Prediction in U.S. Screening Populations	1R37CA292399-01	Claire Zhu, Ph.D.
Neslund-Dudas, Christine Marie	Henry Ford Health + Michigan State University Health Sciences United States	HFH-MSU CSRN ACCrual Enrollment and Screening Site	3UG1CA287007-02S1	Elyse LeeVan, M.D., M.P.H.